This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 98/9/1141    most recent 01.RES.0000219905.16312.28v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, Y.-J. Articles by Newby, A. C. Search for Related Content PubMed PubMed Citation Articles by Wu, Y.-J. Articles by Newby, A. C. Related Collections Cell signalling/signal transduction Gene regulation Growth factors/cytokines Smooth muscle proliferation and differentiation Related Article

(Circulation Research. 2006;98:1141.)
© 2006 American Heart Association, Inc.

Molecular Medicine

Altered S-Phase Kinase-Associated Protein-2 Levels Are a Major Mediator of Cyclic Nucleotide–Induced Inhibition of Vascular Smooth Muscle Cell Proliferation

Yih-Jer Wu^*, Mark Bond^*, Graciela B. Sala-Newby, Andrew C. Newby

From the Bristol Heart Institute, University of Bristol, United Kingdom.

Correspondence to Dr Mark Bond, Bristol Heart Institute, Level 7, Bristol Royal Infirmary, Bristol BS2 8HW, United Kingdom. E-mail mark.bond{at}bristol.ac.uk

Cyclic nucleotides inhibit vascular smooth muscle cell (VSMC) proliferation but the underlying molecular mechanisms are incompletely understood. We studied the role of S-phase kinase-associated protein-2 (Skp2), an F-box protein of SCF^Skp2 ubiquitin ligase responsible for polyubiquitylation of and subsequent proteolysis of p27^Kip1, a key step leading to cell cycle progression. Skp2 mRNA and protein were upregulated in mitogen-stimulated VSMCs and after balloon injury in rat carotid arteries, where the time course and location of Skp2 expression closely paralleled that of proliferating cell nuclear antigen. Skp2 small interference RNA (siRNA) reduced Skp2 expression, increased p27^Kip1 levels, and inhibited VSMC proliferation in vitro. cAMP-elevating agents prominently inhibited VSMC proliferation and Skp2 expression through inhibiting Skp2 transcription as well as decreasing Skp2 protein stability. Consistent with this, activation of protein kinase A, a downstream target of cAMP, was shown to negatively regulate focal adhesion kinase (FAK) phosphorylation and Skp2 expression. Adenovirus-mediated Skp2 expression reversed cAMP-induced p27^Kip1 upregulation and rescued cAMP-related S-phase entry inhibition up to 50%. 8-Bromo-cGMP also moderately reduced Skp2 and cell proliferation when VSMCs were incubated with low serum concentration. Interestingly, we showed that 8-bromo-cGMP inhibited Skp2 expression also through activation of protein kinase A, not protein kinase G, which conversely enhanced FAK_Y397 phosphorylation and Skp2 expression. After balloon injury of rat carotid arteries, local forskolin treatment significantly reduced FAK_Y397 phosphorylation, Skp2 expression, VSMC proliferation, and subsequent neointimal thickening. These data demonstrate for the first time that Skp2 is an important factor in VSMC proliferation and its inhibition by cyclic nucleotides.

Key Words: Skp2 • cyclic nucleotides • smooth muscle cell • proliferation • focal adhesion kinase

Related Article:

Closing the Cycle: Skp2 Modulates Cyclic Nucleotides Antiproliferative Effects

Massimo Chiariello and Giovanni Esposito
Circ. Res. 2006 98: 1113-1114. [Full Text] [PDF]

This article has been cited by other articles:

				M. Bond, Y.-J. Wu, G. B. Sala-Newby, and A. C. Newby Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo Cardiovasc Res, July 30, 2008; (2008) cvn188v3. [Abstract] [Full Text] [PDF]

				I. Ihnatovych, W. Hu, J. L. Martin, A. T. Fazleabas, P. de Lanerolle, and Z. Strakova Increased Phosphorylation of Myosin Light Chain Prevents in Vitro Decidualization Endocrinology, July 1, 2007; 148(7): 3176 - 3184. [Abstract] [Full Text] [PDF]

				M. D. Houslay, G. S. Baillie, and D. H. Maurice cAMP-Specific Phosphodiesterase-4 Enzymes in the Cardiovascular System: A Molecular Toolbox for Generating Compartmentalized cAMP Signaling Circ. Res., April 13, 2007; 100(7): 950 - 966. [Abstract] [Full Text] [PDF]

				M. Chiariello and G. Esposito Closing the Cycle: Skp2 Modulates Cyclic Nucleotides Antiproliferative Effects Circ. Res., May 12, 2006; 98(9): 1113 - 1114. [Full Text] [PDF]